Menopause & Perimenopause in Gurugram

On average around 46, compared with roughly 51 in most Western data. That five-year gap matters more than it sounds: it means symptoms start earlier, it means being told you are too young is frequently wrong, and it means the effects on bone and cardiovascular health begin sooner. Indian guidance also notes that non-communicable disease sets in almost a decade sooner in Indian women.

Perimenopause is the years of change leading up to the last period, when hormone levels swing rather than simply fall. It commonly lasts four to eight years and it is when most symptoms actually occur, often while periods are still coming. Menopause is technically a single day: twelve months after the last period, identified only in hindsight.

Over the age of 45, no. The diagnosis is made on your symptoms and your cycle pattern, and guidance states that investigations are usually not recommended. A blood test is genuinely useful under 40, and can help between 40 and 45 where the diagnosis is less obvious.

No, and this is one of the commonest reasons women are sent away untreated. FSH rises and falls unpredictably during perimenopause, so a single measurement describes that day and very little else. A normal result does not rule out perimenopause, and a raised one is not by itself diagnostic.

Rarely. Oestradiol, LH, progesterone and AMH measured on a random day tell you very little in perimenopause, and such panels are marketed heavily to women. A careful history is worth more than all of them. What is worth checking is thyroid function, haemoglobin and ferritin, blood pressure, sugar, lipids and vitamin D.

Yes, and many women are. Symptoms often begin while cycles are still coming, because the problem is fluctuating hormone levels rather than absent ones. Waiting until periods stop before taking symptoms seriously means waiting through the worst of it.

Far more than hot flushes. Broken sleep, low mood, new anxiety, difficulty concentrating and losing words; new joint and muscle aches and morning stiffness; vaginal dryness, discomfort during sex, urinary urgency and recurrent infections; periods changing in timing or heaviness; palpitations, migraines changing pattern, dry eyes, hair thinning and loss of libido.

They could be, and the two are frequently confused. The combination of broken sleep, low mood, anxiety and brain fog in a woman in her forties is a recognised menopausal pattern. That does not mean depression is never the answer, but it is worth naming the hormonal possibility rather than only treating the mood.

Oestrogen acts on joints and connective tissue, and new aching, morning stiffness or a shoulder that has become painful and restricted is one of the commonest perimenopausal symptoms and one of the least recognised. Women are often investigated for arthritis before anyone mentions hormones.

Common, and often perimenopausal, because cycles stop ovulating reliably and the lining builds up unopposed. But it is a diagnosis to arrive at rather than to assume, and at 45 and over guidance says the lining should be assessed where bleeding persists or treatment has not worked.

The collective name for vaginal dryness, discomfort or pain during sex, urinary urgency and frequency, and recurrent urinary infections. Unlike hot flushes, these symptoms do not settle with time; they progress. They also respond very well to local treatment that most women are never offered.

No, and the difference matters enormously. Vaginal oestrogen is a small dose used locally as a cream, pessary, tablet or ring. It acts where it is put, does not carry the risks of systemic HRT, can be continued for as long as symptoms need it, and can be used alongside HRT or entirely on its own. It is the single most under-offered treatment in menopause care.

Oestrogen, which treats the symptoms, given as a patch, gel, spray or tablet. Plus a progestogen if you still have a uterus, because unopposed oestrogen thickens the lining. The progestogen can be a tablet, part of a combined patch, or a hormonal coil, which has the advantage of controlling perimenopausal bleeding at the same time.

For most women, yes. Oestrogen absorbed through the skin bypasses the liver and does not carry the increased clot risk that oral oestrogen does. That makes a patch or gel the preferred route for many women and particularly for anyone with migraine, a higher BMI or any clotting concern. It is worth asking for by name.

Hot flushes commonly improve within about four weeks, with the full effect by around three months. If nothing has changed by then, the dose or the route should be revisited rather than the treatment abandoned. Vaginal symptoms respond more slowly and tend to return if treatment is stopped.

It increases the risk slightly, and the honest way to express that is in absolute numbers. Of 1,000 women aged 50 taking nothing for five years, about 13 will develop breast cancer. Oestrogen-only HRT adds about 3 more; combined HRT adds about 8 more. Over ten years the figures are 27, plus 7 and plus 20 respectively.

Oral oestrogen carries a small increased risk. Oestrogen through the skin, as a patch or gel, does not appear to. This is one of the clearest and most actionable facts in the subject, and it is the reason the route matters as much as the dose.

Starting near the menopause and under the age of 60 is not associated with increased cardiovascular risk, and oestrogen begun in that window may be protective. Starting many years later, in a woman whose arteries have already changed, is a different proposition. This is why the age at which you start forms part of the discussion.

Because a large trial published in 2002 was widely misread, and for two decades afterwards women were taken off hormone therapy and a generation was largely not offered it. The correction has been slow, and much of what women are still told in clinics dates from that period. If you were refused HRT years ago, that decision is worth revisiting.

There is no arbitrary stopping date, and the old advice to come off after five years regardless has gone. It is reviewed annually, weighing your symptoms against your own risk profile. For premature ovarian insufficiency it is normally continued until at least the age of 51.

It needs an individual discussion, usually alongside your oncologist, and systemic HRT is often not appropriate. Two things are worth knowing: that conversation is generally about systemic treatment specifically, and local vaginal treatment is frequently still possible. Menopause-specific CBT and non-hormonal prescription options are also genuinely effective, so being unable to take HRT does not mean being untreated.

The ovaries stopping before the age of 40. It is diagnosed with FSH measured twice, four to six weeks apart, alongside the clinical picture, and it deserves a proper diagnosis rather than reassurance. Hormone therapy here is replacement of what should still be present, normally continued until at least 51, and the risk conversation that applies to a woman in her fifties does not apply.

The menopause between the ages of 40 and 45. It is common enough in India that it should not be treated as unusual, and it is one of the situations where a blood test genuinely has a role. It also warrants attention to bone and cardiovascular health earlier than usual.

Yes, until either two years after your last period if you are under 50, or one year after if you are over 50. Fertility falls but does not disappear, and unplanned pregnancies in the forties are commoner than people expect. A hormonal coil is a useful option because it also controls bleeding and can provide the progestogen part of HRT.

Yes, and it is not a consolation prize. Menopause-specific cognitive behavioural therapy reduces the frequency and severity of hot flushes and night sweats and improves sleep and mood, and guidance supports it either alongside HRT or as an evidence-based alternative for women who cannot or would rather not take hormones.

Most of what is sold in this space has poor evidence and heavy marketing behind it, including long supplement panels and compounded so-called bioidentical hormones prepared to order. Regulated body-identical hormone therapy is a different thing entirely, and is what is actually prescribed.

Fat redistributes towards the abdomen as oestrogen falls, and muscle mass declines with age unless it is actively maintained. That is a hormonal and physiological shift rather than a failure of discipline, and it is worth saying so. Resistance exercise addresses it more effectively than dieting alone.

Take it seriously and take it early. Peak bone density in Indian women is markedly lower to begin with and vitamin D deficiency is close to universal here, so calcium, vitamin D and weight-bearing exercise are not optional advice. Where bone density scanning is not readily available, validated risk tools can identify who most needs it.

It needs assessing promptly. Any bleeding after your periods have stopped for a full year is benign in the large majority of women, but it is the one symptom that should never be watched or waited out. New unexpected bleeding on HRT deserves the same prompt assessment.

A note of your cycles if you still have them, and a list of every symptom including the ones that feel unconnected to each other. Any hormone results you have already been given. Your medicines. And if you were refused HRT some years ago, the details of that, because it is often worth revisiting.